PLoS ONE (Jan 2021)

Interactome analysis of Bag-1 isoforms reveals novel interaction partners in endoplasmic reticulum-associated degradation.

  • Nisan Denizce Can,
  • Ezgi Basturk,
  • Tugba Kizilboga,
  • Izzet Mehmet Akcay,
  • Baran Dingiloglu,
  • Ozge Tatli,
  • Sevilay Acar,
  • Pelin Ozfiliz Kilbas,
  • Efe Elbeyli,
  • Serena Muratcioglu,
  • Ayse Tarbin Jannuzzi,
  • Attila Gursoy,
  • Ozlem Keskin,
  • Hamdi Levent Doganay,
  • Betul Karademir Yilmaz,
  • Gizem Dinler Doganay

DOI
https://doi.org/10.1371/journal.pone.0256640
Journal volume & issue
Vol. 16, no. 8
p. e0256640

Abstract

Read online

Bag-1 is a multifunctional protein that regulates Hsp70 chaperone activity, apoptosis, and proliferation. The three major Bag-1 isoforms have different subcellular localizations and partly non-overlapping functions. To identify the detailed interaction network of each isoform, we utilized mass spectrometry-based proteomics and found that interactomes of Bag-1 isoforms contained many common proteins, with variations in their abundances. Bag-1 interactomes were enriched with proteins involved in protein processing and degradation pathways. Novel interaction partners included VCP/p97; a transitional ER ATPase, Rad23B; a shuttling factor for ubiquitinated proteins, proteasome components, and ER-resident proteins, suggesting a role for Bag-1 also in ER-associated protein degradation (ERAD). Bag-1 pull-down from cells and tissues from breast cancer patients validated these interactions and showed cancer-related prominence. Using in silico predictions we detected hotspot residues of Bag-1. Mutations of these residues caused loss of binding to protein quality control elements and impaired proteasomal activity in MCF-7 cells. Following CD147 glycosylation pattern, we showed that Bag-1 downregulated VCP/p97-dependent ERAD. Overall, our data extends the interaction map of Bag-1, and broadens its role in protein homeostasis. Targeting the interaction surfaces revealed in this study might be an effective strategy in the treatment of cancer.